Ads
related to: solriamfetol- Cost Of SUNOSI
Learn about the affordability of
SUNOSI. See the savings program.
- Common Side Effects
Here's what you need to
know about possible side effects.
- Get A Savings Card
You may pay as little as
$9 a month for SUNOSI.
- Read The Dosing Info
Learn about the dosing
considerations of SUNOSI.
- Savings Card
Learn more about affordability
with our savings card program.
- See The Study Data
View efficacy & safety data and
learn more about SUNOSI.
- Cost Of SUNOSI
Search results
Axsome (AXSM) Begins Solriamfetol Binge Eating Phase III Study
Zacks via Yahoo Finance· 2 months agoAxsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol...
Axsome (AXSM) Doses First Patient in Late-Stage ADHD Study
Zacks via Yahoo Finance· 11 months agoAxsome AXSM announced that the first patient has been dosed in the late-stage, label expansion study...
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Axsome Therapeutics (NASDAQ: AXSM) Q1 2024 Earnings Call May 06,...
Axsome (AXSM) Q4 Earnings Miss, Auvelity Records First Sales
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.28 per share in the fourth quarter of...
Axsome Triumphs Over Major Depressive Disorder With Auvelity
GuruFocus.com via Yahoo Finance· 2 months agoAxsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in New...
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Zacks via Yahoo Finance· 3 months agoIt was a busy week for the biotech sector with lots of study data readouts and regulatory approvals....
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics’ AXSM shares have surged 118.4% in the past three months against the industry’s...
Axsome (AXSM) Q3 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics, Inc. AXSM incurred a loss of $1.03 per share (excluding intangible asset...
Q4 2023 Axsome Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Mark Jacobson; COO & Secretary; Axsome Therapeutics, Inc. Herriot Tabuteau; Founder, Chairman, CEO & President; Axsome Therapeutics, Inc. Nick Pizzie; CFO; Axsome Therapeutics, ...
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
Zacks via Yahoo Finance· 3 months agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of 73 cents per share for the fourth...
Ads
related to: solriamfetol
